Wealthcare Advisory Partners’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-400
Closed -$9K 1457
2019
Q3
$9K Hold
400
﹤0.01% 959
2019
Q2
$8K Hold
400
﹤0.01% 972
2019
Q1
$9K Hold
400
﹤0.01% 850
2018
Q4
$9K Sell
400
-600
-60% -$13.7K ﹤0.01% 826
2018
Q3
$25K Buy
1,000
+400
+67% +$10.2K ﹤0.01% 624
2018
Q2
$15K Buy
+600
New +$14.8K ﹤0.01% 745

Other funds holding LDRS

Wealthcare Advisory Partners's LDRS Position: Q4 2019 in Review

Wealthcare Advisory Partners sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q4 2019, closing a stake of 400 shares — an estimated $9K sold.

Wealthcare Advisory Partners first reported a position in LDRS in Q2 2018 and held it in 6 quarters. The position peaked at $25K in Q3 2018. 10 funds tracked by Wall St. Rank hold LDRS as of Q4 2019.

  • Wealthcare Advisory Partners reported no remaining Innovator IBD ETF Leaders ETF position as of Q4 2019 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 400 Innovator IBD ETF Leaders ETF shares in Q4 2019, an estimated $9K.
  • Wealthcare Advisory Partners first reported a position in Innovator IBD ETF Leaders ETF in Q2 2018 and held it in 6 quarters.
  • Wealthcare Advisory Partners's Innovator IBD ETF Leaders ETF position peaked at $25K in Q3 2018.
  • 10 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q4 2019.

Based on Wealthcare Advisory Partners's 13F filing for Q4 2019, filed 29 Jan 2020.